Dr. Andrew D. Seidman on Targeted Treatments in Breast Cancer
December 22nd 2015​Andrew D. Seidman, MD, attending physician, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, discusses the shift paradigm of breast cancer treatment and the development of targeted agents that disrupt certain pathways.